ILMN – Illumina, Inc.
ILMN — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
4.87
Margin Of Safety %
-3
Put/Call OI Ratio
0.47
EPS Next Q Diff
-0.11
EPS Last/This Y
-0.35
EPS This/Next Y
0.72
Price
117.62
Target Price
135.56
Analyst Recom
2.35
Performance Q
-13.04
Upside
2.1%
Beta
1.49
Ticker: ILMN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | ILMN | 134.49 | 0.52 | 0.16 | 36785 |
| 2026-03-02 | ILMN | 132.98 | 0.53 | 0.13 | 36849 |
| 2026-03-03 | ILMN | 129.67 | 0.53 | 0.76 | 36949 |
| 2026-03-04 | ILMN | 129.03 | 0.54 | 0.05 | 37162 |
| 2026-03-05 | ILMN | 128.21 | 0.55 | 2.02 | 36908 |
| 2026-03-06 | ILMN | 124.66 | 0.52 | 0.22 | 35704 |
| 2026-03-09 | ILMN | 124.27 | 0.53 | 0.67 | 35523 |
| 2026-03-10 | ILMN | 122.05 | 0.53 | 6.08 | 35339 |
| 2026-03-11 | ILMN | 121.49 | 0.53 | 5.54 | 35527 |
| 2026-03-12 | ILMN | 115.54 | 0.50 | 0.30 | 34665 |
| 2026-03-13 | ILMN | 115.56 | 0.50 | 0.31 | 34665 |
| 2026-03-17 | ILMN | 120.89 | 0.52 | 0.15 | 36042 |
| 2026-03-18 | ILMN | 122.92 | 0.52 | 0.21 | 36091 |
| 2026-03-19 | ILMN | 126.54 | 0.52 | 1.51 | 36123 |
| 2026-03-20 | ILMN | 124.34 | 0.52 | 0.87 | 36153 |
| 2026-03-23 | ILMN | 123.78 | 0.48 | 0.92 | 16137 |
| 2026-03-24 | ILMN | 126.03 | 0.48 | 0.28 | 16297 |
| 2026-03-25 | ILMN | 126.31 | 0.47 | 0.41 | 16459 |
| 2026-03-26 | ILMN | 124.44 | 0.47 | 0.39 | 16563 |
| 2026-03-27 | ILMN | 117.61 | 0.47 | 2.29 | 16594 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | ILMN | 134.49 | 9.2 | -133.3 | 5.13 |
| 2026-03-02 | ILMN | 132.92 | 9.2 | -151.8 | 5.13 |
| 2026-03-03 | ILMN | 129.57 | 9.2 | -165.4 | 5.13 |
| 2026-03-04 | ILMN | 129.02 | 9.2 | -144.5 | 5.13 |
| 2026-03-05 | ILMN | 128.22 | 9.2 | -146.2 | 5.13 |
| 2026-03-06 | ILMN | 124.66 | 9.2 | -168.1 | 5.13 |
| 2026-03-09 | ILMN | 124.27 | 9.2 | -143.1 | 5.13 |
| 2026-03-10 | ILMN | 122.40 | 9.2 | -155.4 | 5.13 |
| 2026-03-11 | ILMN | 121.52 | 9.2 | -147.1 | 5.13 |
| 2026-03-12 | ILMN | 115.54 | 9.2 | -189.3 | 5.13 |
| 2026-03-13 | ILMN | 118.89 | 9.2 | -111.7 | 5.13 |
| 2026-03-17 | ILMN | 120.86 | 9.2 | -127.1 | 5.12 |
| 2026-03-18 | ILMN | 122.94 | 9.2 | -123.0 | 5.12 |
| 2026-03-19 | ILMN | 126.54 | 9.2 | -145.6 | 5.12 |
| 2026-03-20 | ILMN | 124.33 | 9.2 | -191.1 | 5.12 |
| 2026-03-23 | ILMN | 123.78 | 9.2 | -178.1 | 5.12 |
| 2026-03-24 | ILMN | 126.03 | 9.2 | -156.4 | 5.12 |
| 2026-03-25 | ILMN | 126.19 | 9.2 | -172.2 | 5.12 |
| 2026-03-26 | ILMN | 124.43 | 9.2 | -187.5 | 5.12 |
| 2026-03-27 | ILMN | 117.62 | 9.2 | -226.6 | 5.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | ILMN | -0.09 | -3.63 | 5.33 |
| 2026-03-02 | ILMN | -0.09 | 0.87 | 5.33 |
| 2026-03-03 | ILMN | -0.09 | 0.87 | 5.33 |
| 2026-03-04 | ILMN | -0.09 | 0.87 | 5.33 |
| 2026-03-05 | ILMN | -0.09 | 0.87 | 5.33 |
| 2026-03-06 | ILMN | -0.09 | 0.87 | 5.33 |
| 2026-03-09 | ILMN | -0.09 | 0.79 | 5.33 |
| 2026-03-10 | ILMN | -0.09 | 0.79 | 5.33 |
| 2026-03-11 | ILMN | -0.09 | 0.79 | 4.82 |
| 2026-03-12 | ILMN | -0.09 | 0.79 | 4.82 |
| 2026-03-13 | ILMN | -0.09 | 0.79 | 4.82 |
| 2026-03-17 | ILMN | -0.09 | 0.84 | 4.82 |
| 2026-03-18 | ILMN | -0.09 | 0.84 | 4.82 |
| 2026-03-19 | ILMN | -0.09 | 0.84 | 4.82 |
| 2026-03-20 | ILMN | -0.09 | 0.84 | 4.82 |
| 2026-03-23 | ILMN | -0.09 | 0.78 | 4.82 |
| 2026-03-24 | ILMN | -0.09 | 0.78 | 4.82 |
| 2026-03-25 | ILMN | -0.09 | 0.78 | 4.87 |
| 2026-03-26 | ILMN | -0.09 | 0.78 | 4.87 |
| 2026-03-27 | ILMN | -0.09 | 0.78 | 4.87 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.35
Avg. EPS Est. Current Quarter
1.06
Avg. EPS Est. Next Quarter
1.24
Insider Transactions
-0.09
Institutional Transactions
0.78
Beta
1.49
Average Sales Estimate Current Quarter
1073
Average Sales Estimate Next Quarter
1105
Fair Value
114.28
Quality Score
94
Growth Score
41
Sentiment Score
60
Actual DrawDown %
77
Max Drawdown 5-Year %
-86.2
Target Price
135.56
P/E
21.54
Forward P/E
20.16
PEG
1.79
P/S
4.14
P/B
6.61
P/Free Cash Flow
19.33
EPS
5.46
Average EPS Est. Cur. Y
5.12
EPS Next Y. (Est.)
5.84
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
19.58
Relative Volume
0.6
Return on Equity vs Sector %
3.9
Return on Equity vs Industry %
20.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
-226.6
◆
ILMN
Healthcare
$117.67
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
39.6
Range 1M
13.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
6%
EPS NY
13.8%
52W%
56.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+6.8% upside
Upside
+6.8%
Quality
94
MoS
-3%
Illumina, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 8600
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
ILMN
Latest News
—
Caricamento notizie per ILMN…
stock quote shares ILMN – Illumina, Inc. Stock Price stock today
news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ILMN – Illumina, Inc. yahoo finance google finance
stock history ILMN – Illumina, Inc. invest stock market
stock prices ILMN premarket after hours
ticker ILMN fair value insiders trading